MicrobiologybioRxivPreprint
LAVR-289, a new acyclo-nucleoside phosphonate having broad-spectrum activity against herpesviruses.
Sandrine Kappler‐Gratias, Charlotte Quentin-Froignant, Elie Marcheteau…·Franck Gallardo
This study evaluates LAVR-289, a new antiviral compound, showing broad-spectrum activity against herpesviruses and resistance to existing treatments.
DOI 10.1101/2025.02.20.639249